January 08, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth : ALIMP, FR0010458729, PEA-PME eligible ; OTCQX : IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today is announcing its annual report on its liquidity contract with TSAF as of December 31, 2017. Pursuant to the liquidity contract entrusted by the […]